{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:00:47Z","timestamp":1783972847362,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-021-02277-0","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T12:11:27Z","timestamp":1631621487000},"page":"729-738","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Role of botulinum toxin A in improving facial erythema and skin quality"],"prefix":"10.1007","volume":"314","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3211-565X","authenticated-orcid":false,"given":"Edith","family":"Hanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer H.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vince","family":"Bertucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,14]]},"reference":[{"issue":"7","key":"2277_CR1","first-page":"454","volume":"54","author":"G Eshghi","year":"2016","unstructured":"Eshghi G, Khezrian L, Alirezaei P (2016) Botulinum toxin-a in treatment of facial flushing. Acta Med Iran 54(7):454\u2013457","journal-title":"Acta Med Iran"},{"issue":"12","key":"2277_CR2","first-page":"e76","volume":"11","author":"SH Dayan","year":"2012","unstructured":"Dayan SH, Pritzker RN, Arkins JP (2012) A new treatment regimen for rosacea: onabotulinumtoxin A. J Drugs Dermatol 11(12):e76\u2013e79","journal-title":"J Drugs Dermatol"},{"issue":"9","key":"2277_CR3","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1097\/DSS.0000000000001819","volume":"45","author":"MJ Kim","year":"2019","unstructured":"Kim MJ, Kim JH, Cheon HI, Hur MS, Han SH, Lee YW et al (2019) Assessment of skin physiology change and safety after intradermal injections with botulinum toxin: a randomized, double-blind, placebo-controlled, split-face pilot study in rosacea patients with facial erythema. Dermatol Surg 45(9):1155\u20131162","journal-title":"Dermatol Surg"},{"key":"2277_CR4","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1097\/DSS.0000000000000277","volume":"41","author":"BS Bloom","year":"2015","unstructured":"Bloom BS, Payongayong L, Mourin A, Goldberg DJ (2015) Impact of intradermal abobotulinumtoxin A on facial erythema of rosacea. Dermatol Surg 41:S9-16","journal-title":"Dermatol Surg"},{"issue":"6","key":"2277_CR5","doi-asserted-by":"publisher","first-page":"688","DOI":"10.5021\/ad.2018.30.6.688","volume":"30","author":"KY Park","year":"2018","unstructured":"Park KY, Kwon HJ, Kim JM, Jeong GJ, Kim BJ, Seo SJ et al (2018) A pilot study to evaluate the efficacy and safety of treatment with botulinum toxin in patients with recalcitrant and persistent erythematotelangiectatic rosacea. Ann Dermatol 30(6):688\u2013693","journal-title":"Ann Dermatol"},{"issue":"8","key":"2277_CR6","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/jamadermatol.2014.4728","volume":"151","author":"YR Helfrich","year":"2015","unstructured":"Helfrich YR, Maier LE, Cui Y, Fisher GJ, Chubb H, Fligiel S et al (2015) Clinical, histologic, and molecular analysis of differences between erythematotelangiectatic rosacea and telangiectatic photoaging. JAMA Dermatol 151(8):825\u2013836","journal-title":"JAMA Dermatol"},{"issue":"5","key":"2277_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.7150\/ijms.10608","volume":"12","author":"RC Vemuri","year":"2015","unstructured":"Vemuri RC, Gundamaraju R, Sekaran SD, Manikam R (2015) Major pathophysiological correlations of rosacea: a complete clinical appraisal. Int J Med Sci 12(5):387\u2013396","journal-title":"Int J Med Sci"},{"issue":"4","key":"2277_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/lsm.23023","volume":"51","author":"O Friedman","year":"2019","unstructured":"Friedman O, Koren A, Niv R, Mehrabi JN, Artzi O (2019) The toxic edge\u2014a novel treatment for refractory erythema and flushing of rosacea. Lasers Surg Med 51(4):325\u2013331","journal-title":"Lasers Surg Med"},{"issue":"1\u20132","key":"2277_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000446215","volume":"2","author":"M Abokwidir","year":"2016","unstructured":"Abokwidir M, Feldman SR (2016) Rosacea management. Ski Appendage Disord 2(1\u20132):26\u201334","journal-title":"Ski Appendage Disord"},{"key":"2277_CR10","unstructured":"Taylor JH (2017) Antimicrobial peptides [Internet]. dermnetnz.govt.nz [cited 2020 Mar 12]. Available from: http:\/\/www.dermnetnz.org\/topics\/antimicrobial-peptides.\nAccessed 15 July 2020"},{"issue":"4","key":"2277_CR11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.burns.2012.07.031","volume":"39","author":"TH Park","year":"2013","unstructured":"Park TH (2013) The effects of botulinum toxin A on mast cell activity: preliminary results. Burns 39(4):816\u2013817","journal-title":"Burns"},{"issue":"1","key":"2277_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jdermsci.2018.12.004","volume":"93","author":"JE Choi","year":"2019","unstructured":"Choi JE, Werbel T, Wang Z, Wu CC, Yaksh TL, Di Nardo A (2019) Botulinum toxin blocks mast cells and prevents rosacea like inflammation. J Dermatol Sci 93(1):58\u201364","journal-title":"J Dermatol Sci"},{"issue":"6","key":"2277_CR13","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.jaad.2016.01.023","volume":"74","author":"A Di Nardo","year":"2016","unstructured":"Di Nardo A, Holmes AD, Muto Y, Huang EY, Preston N, Winkelman WJ, Gallo RL (2016) Improved clinical outcome and biomarkers in adults with papulopustular rosacea treated with doxycycline modified-release capsules in a randomized trial. J Am Acad Dermatol 74(6):1086\u20131092","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"2277_CR14","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1111\/j.1524-4725.2012.02504.x","volume":"38","author":"SH Oh","year":"2012","unstructured":"Oh SH, Lee Y, Seo YJ, Lee JH, Yang JD, Chung HY, Cho BC (2012) The potential effect of botulinum toxin type A on human dermal fibroblasts: an in vitro study. Dermatol Surg 38(10):1689\u20131694","journal-title":"Dermatol Surg"},{"issue":"1","key":"2277_CR15","doi-asserted-by":"publisher","first-page":"e12433","DOI":"10.1111\/dth.12433","volume":"30","author":"J Zhu","year":"2016","unstructured":"Zhu J, Ji X, Xu Y, Liu J, Miao Y, Zhang J et al (2016) The efficacy of intradermal injection of type A botulinum toxin for facial rejuvenation. Dermatol Ther 30(1):e12433","journal-title":"Dermatol Ther"},{"issue":"4","key":"2277_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000368773","volume":"230","author":"K Park","year":"2015","unstructured":"Park K, Hyun M, Jeong S, Kim B, Kim M, Hong C (2015) Botulinum toxin for the treatment of refractory erythema and flushing of rosacea. Dermatology 230(4):299\u2013301","journal-title":"Dermatology"},{"key":"2277_CR17","first-page":"e13976","volume":"33","author":"F Al-Niaimi","year":"2020","unstructured":"Al-Niaimi F, Glagoleva E, Araviiskaia E (2020) Pulsed dye laser followed by intradermal botulinum toxin type-A in the treatment of rosacea-associated erythema and flushing. Dermatol Ther 33:e13976","journal-title":"Dermatol Ther"},{"issue":"5","key":"2277_CR18","doi-asserted-by":"publisher","first-page":"92S","DOI":"10.1097\/PRS.0000000000001827","volume":"136","author":"WTL Wu","year":"2015","unstructured":"Wu WTL (2015) Microbotox of the lower face and neck: evolution of a personal technique and its clinical effects. Plast Reconstr Surg 136(5):92S-100S","journal-title":"Plast Reconstr Surg"},{"issue":"8","key":"2277_CR19","first-page":"49","volume":"10","author":"DC Endly","year":"2017","unstructured":"Endly DC, Miller RA (2017) Oily skin: a review of treatment options. J Clin Aesthet Dermatol 10(8):49\u201355","journal-title":"J Clin Aesthet Dermatol"},{"issue":"9","key":"2277_CR20","first-page":"847","volume":"7","author":"AR Shah","year":"2008","unstructured":"Shah AR (2008) Use of intradermal botulinum toxin to reduce sebum production and facial pore size. J Drugs Dermatol 7(9):847\u2013850","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"2277_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jdermsci.2013.06.009","volume":"72","author":"ZJ Li","year":"2013","unstructured":"Li ZJ, Park SB, Sohn KC et al (2013) Regulation of lipid production by acetylcholine signalling in human sebaceous glands. J Dermatol Sci 72(2):116\u2013122","journal-title":"J Dermatol Sci"},{"issue":"3 PART 1","key":"2277_CR22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/dsu.12097","volume":"39","author":"AE Rose","year":"2013","unstructured":"Rose AE, Goldberg DJ (2013) Safety and efficacy of intradermal injection of botulinum toxin for the treatment of oily skin. Dermatol Surg 39(3 PART 1):443\u2013448","journal-title":"Dermatol Surg"},{"key":"2277_CR23","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1708241","author":"KS Sayed","year":"2020","unstructured":"Sayed KS, Hegazy R, Gawdat HI et al (2020) The efficacy of intradermal injections of botulinum toxin in the management of enlarged facial pores and seborrhea: a split face-controlled study. J Dermatol Treat. https:\/\/doi.org\/10.1080\/09546634.2019.1708241","journal-title":"J Dermatol Treat"},{"issue":"5","key":"2277_CR24","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/j.1365-2133.2006.07465.x","volume":"155","author":"M Roh","year":"2006","unstructured":"Roh M, Han M, Kim D, Chung K (2006) Sebum output as a factor contributing to the size of facial pores. Br J Dermatol 155(5):890\u2013894","journal-title":"Br J Dermatol"},{"issue":"5","key":"2277_CR25","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1097\/PRS.0000000000007248","volume":"146","author":"A Diaspro","year":"2020","unstructured":"Diaspro A, Calvisi L, Manzoni V, Sito G (2020) Microbotulinum: a quantitative evaluation of aesthetic skin improvement in 62 patients. Plast Reconstr Surg 146(5):987\u2013994","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"2277_CR26","first-page":"1","volume":"10","author":"P Sapra","year":"2017","unstructured":"Sapra P, Demay S, Sapra S, Khanna J, Mraud K, Bonadonna J (2017) A single-blind, split-face, randomized, pilot study comparing the effects of intradermal and intramuscular injection of two commercially available botulinum toxin a formulas to reduce signs of facial aging. J Clin Aesthet Dermatol 10(2):1\u201314","journal-title":"J Clin Aesthet Dermatol"},{"issue":"2","key":"2277_CR27","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/jocd.12866","volume":"18","author":"L Shuo","year":"2019","unstructured":"Shuo L, Ting Y, KeLun W, Rui Z, Rui Z, Hang W (2019) Efficacy and possible mechanisms of botulinum toxin treatment of oily skin. J Cosmet Dermatol 18(2):451\u2013457","journal-title":"J Cosmet Dermatol"},{"issue":"SUPPL. 4","key":"2277_CR28","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1111\/j.1524-4725.2010.01703.x","volume":"36","author":"R Kapoor","year":"2010","unstructured":"Kapoor R, Shome D, Jain V, Dikshit R (2010) Facial rejuvenation after intradermal botulinum toxin: Is it really the botulinum toxin or is it the pricks? Dermatol Surg 36(SUPPL. 4):2098\u20132105","journal-title":"Dermatol Surg"},{"issue":"2","key":"2277_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/srt.12094","volume":"20","author":"S Luebberding","year":"2014","unstructured":"Luebberding S, Krueger N, Kerscher M (2014) Mechanical properties of human skin in vivo: a comparative evaluation in 300 men and women. Ski Res Technol 20(2):127\u2013135","journal-title":"Ski Res Technol"},{"issue":"4","key":"2277_CR30","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1001\/jamafacial.2015.0376","volume":"17","author":"JP Bonaparte","year":"2015","unstructured":"Bonaparte JP, Ellis D (2015) Alterations in the elasticity, pliability, and viscoelastic properties of facial skin after injection of onabotulinum Toxin A. JAMA Facial Plast Surg 17(4):256\u2013263","journal-title":"JAMA Facial Plast Surg"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-021-02277-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-021-02277-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-021-02277-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T17:09:21Z","timestamp":1661274561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-021-02277-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,14]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["2277"],"URL":"https:\/\/doi.org\/10.1007\/s00403-021-02277-0","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,14]]},"assertion":[{"value":"23 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}